Page 60 - FINAL PROGRAMME 2017

10:45 O-030
11:00 O-031
Superiority of array Comparative Genome Hybridization (aCGH) over Next Generation Sequencing (NGS) for PGD for reciprocal translocations
T. Escudero1,2, A. Erin3, M. Santiago2
1Reprogenetics, aCGH Team, Livingston- New Jersey, U.S.A.
2Reprogenetics- A CooperSurgical Company, Research, Livingston- New Jersey, U.S.A. 3Reprogenetics- A CooperSurgical Company, Genetic Counselor, Livingston- New Jersey, U.S.A.
Development, validation and rst clinical application of a novel ultra-rapid comprehensive chromosome screening technique utilising an array based nano scale quantitative DNA ampli cation technology
K. Spath1,2, N. Kubikova1,2, M. Whitney3, M. Vaid3, G. Rozis3, V. Couchman3, K. Glynn3, S. Batha3, S. Alfarawati1, E. Fragouli1, D. Wells1,2
1Reprogenetics UK, Institute of Reproductive Sciences, Oxford, United Kingdom
2University of Oxford, Nuf eld Department of Obstetrics and Gynaecology, Oxford, United Kingdom 3The Lister Fertility Clinic, Lister Hospital, London, United Kingdom
A novel next generation sequencing (NGS)-based comprehensive chromosome screening (CCS) platform that provides accurate copy number and genotyping in parallel from a single trophectoderm biopsy
D. Marin1, R. Zimmerman2, C. Jalas2, X. Tao2, Y. Zhan2, R. Scott1, N. Treff1
1Reproductive Medicine Associates of New Jersey, Molecular Biology, Basking Ridge, U.S.A. 2Foundation for Embryonic Competence, Clinical Genetics, Basking Ridge, U.S.A.
11:15 O-032
60